- Home
- PEBO vs KRSA Comparison
PEBO vs KRSA Comparison
Compare PEBO & KRSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PEBO | KRSA |
|---|---|---|
| Founded | 1902 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2006 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PEBO | KRSA |
|---|---|---|
| Price | $38.46 | $31.53 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $42.83 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 395.3K | 158.7K |
| Earning Date | 10-20-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.39% | N/A |
| EPS Growth | N/A | ★ 8.26 |
| EPS | ★ 2.49 | N/A |
| Revenue | $197,000.00 | ★ $2,074,000.00 |
| Revenue This Year | $7.15 | N/A |
| Revenue Next Year | $55.89 | N/A |
| P/E Ratio | $15.34 | ★ N/A |
| Revenue Growth | N/A | ★ 3.70 |
| 52 Week Low | $28.23 | $29.03 |
| 52 Week High | $42.29 | $37.27 |
Technical Indicators
Market Signals| Indicator | PEBO | KRSA |
|---|---|---|
| Relative Strength Index (RSI) | 50.91 | 50.47 |
| Support Level | $37.53 | $29.67 |
| Resistance Level | $39.33 | $34.51 |
| Average True Range (ATR) | 0.81 | 1.87 |
| MACD | -0.03 | 0.18 |
| Stochastic Oscillator | 17.26 | 64.84 |
Price Performance
Historical ComparisonAbout PEBO Peoples Bancorp Inc.
Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.
About KRSA Korsana Biosciences Inc. Common Stock
Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibody that combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.